Skip to main content
. 2018 Aug 9;4:84. doi: 10.1038/s41420-018-0086-x

Fig. 2. Comparative metabolomics indicates that glutamine-related metabolism affects the sensitivity of NSCLCs to gefitinib.

Fig. 2

a, b Heat map representation of a 2D hierarchical clustering of metabolites identified as differentially changed in A549 cells (a) and PC-9 cells (b) after treatment with gefitinib compared to control cells. Each column represents a treatment group, and each row represents a metabolite